AddressJob No.: 664702
Location: Turning Point, 110 Church Street, Richmond
Employment Type: Full-time
Duration: 3-year fixed-term appointment
Remuneration: The successful applicant will receive a tax-free stipend, at the current value of $35,013 per annum 2024 full-time rate, as per the Monash Research Training Program (RTP) Stipend www.monash.edu/study/fees-scholarships/scholarships/find-a-scholarship/research-training-program-scholarship#scholarship-details
- Be inspired, every day
- Drive your own learning at one of the world’s top 80 universities
- Take your career in exciting, rewarding directions
About the project
Trauma and addiction frequently co-occur. About 1 in 2 people in addiction treatment settings have symptoms of PTSD, yet integrated treatment is not routinely available. This PhD program is aimed at translational approaches to integrated treatment for PTSD and addiction, with an exciting opportunity to be involved in both frontline clinics and desktop secondary analyses of existing datasets. The program will focus on transdiagnostic correlates of co-occurring disorders, including neurobiological, neuropsychological and neurophysiological underpinnings of presenting problems.
The program is supported by projects across three NHMRC and MRFF grants, including a NHMRC Investigator Fellowship (Arunogiri), enabling the student to work across a number of national multisite clinical trials, including a study of Psychedelic Assisted Psychotherapy (PAT) with MDMA assisted psychotherapy for PTSD and alcohol use disorder.
This PhD program would suit applicants from a psychology, psychiatry or related mental health background.
Turning Point and Monash University
The successful candidate will be part of a multidisciplinary cohort of researchers and students based at Turning Point, Australia’s leading national addiction treatment, training and research centre, based in Melbourne, Australia. For more information about the important work that Turning Point does, please visit the website.
Turning Point is affiliated with Eastern Health Clinical School, within the Faculty of Medicine, Nursing and Health Sciences (MNHS) at Monash University, and undertakes close collaborative work with the Monash Addiction Research Centre (MARC).
Monash University is a member of Australia’s Group of Eight coalition, and is internationally recognized for excellence in research and teaching as one of the world's top 80 universities. Embedded in an ecosystem of health, academia and industry, it delivers the research outcomes, skilled workforce, technology and partnerships to improve human health locally and globally.
Supervisory team
The principal supervisor will be Associate Professor Shalini Arunogiri. Co-supervisors will be dependent on the project focus, and may include supervisors at Turning Point and/or Monash Addiction Research Centre, or externally.
A/Prof Arunogiri is an Associate Professor of Addiction Studies at Monash University, Clinical Director of the Hamilton Centre, and a Strategic Lead of the Clinical & Social Research (CSR) team at Turning Point. As a clinical addiction psychiatrist, she has extensive experience working across alcohol and other drug (AOD) and mental health services, with a research focus on clinical research into novel treatments for substance use disorders and integrated treatments for co-occuring mental health problems.
Eligibility Requirements
Candidates will need to fulfil the Monash University minimum requirements for admission to a PhD detailed here: www.monash.edu/admissions/entry-requirements/minimum.
How to apply
For general instructions on how to apply for roles at Monash, please refer to 'How to apply for Monash Jobs'.
To express your interest in this scholarship and PhD research opportunity, we request candidates provide:
- A cover letter describing your research interests and why you would like to undertake a PhD (maximum one page)
- A CV including qualifications, academic achievements, list of publications, work history and references;
- A copy of your academic transcript(s)
Enquiries
Turning Point Research Support, ***************@monash.edu
COVID 19 vaccination is recommended for all persons attending a Monash University location. Staff located within a healthcare setting and students on placement in a healthcare setting must comply with the COVID-19 vaccination direction of the host organisation.
For the latest information on COVID-19 at Monash, please visit our website.
Supporting a diverse workforce
Monash University recognises that its Australian campuses are located on the unceded lands of the people of the Kulin nations, and pays its respects to their elders, past and present.
